“During a period of very volatile prices, our investing strategy works when prices are high or when they are low,” Waterous said.
'Sometimes it can be hard to find category leaders at a smaller scale, but when you find one, it is really special,' says Thoma Bravo's Carl Press.
Clearlake is acquiring Intertape Polymer Group, a Montreal packaging company, for $2.6bn in a take-private deal announced earlier this month.
The impact of a new SEC climate disclosure proposal for publicly traded companies could be felt in private markets.
The AIC model 'offers a unique value proposition to balance the needs of constituents in the ecosystem,' InTandem's Brad Coppens said.
The combined business will now be reaching a combined 70,000 healthcare practitioners and over 5 million patients. 'Now we have a really large platform that is driving market growth within integrative health,' said HGGC’s Bill Conrad.
"We're not buying the market, we're not buying the region, we're not buying an index," EQT CEO Christian Sinding told PE Hub. "We're buying a high-performing private equity firm that's been navigating this area for a long time."
“Every drug since 2010, was invented by a university and by partnering with over 20 large universities, we are teaming up with the source of innovation and hopefully that leads to a differentiated return," said Deerfield's Jim Flynn.
“The goal was to lower costs, improve clinical outcomes and actively manage towards an overall healthier population," said VSS’ David Bainbridge.
"There are still areas where hospitals aren’t leveraging technology, and that’s a big problem," Berenson Capital’s Brendyn Grimaldi said.